Investor Alert

Cerecor Inc.



After Hours

 --Quotes are delayed by 20 min

May 22, 2020, 6:47 p.m.





-0.03 -1.26%


Volume 600

Quotes are delayed by 20 min


Previous close

$ 2.26

$ 2.38


+0.12 +5.31%

Day low

Day high




52 week low

52 week high




Simon C. Pedder

Simon C. Pedder is a businessperson who founded Chelsea Therapeutics International Ltd. and who has been at the head of 6 different companies. Currently, he is Executive Chairman & President at Cerecor, Inc. He is also on the board of Eboo Pharmaceuticals, Inc., Ballantyne Therapeutics, Inc. and Atlantic Research Group, Inc. and Chief Business & Strategy Officer-Proprietary at Athenex, Inc.

In his past career he occupied the position of President, Chief Executive Officer & Director at Cellectar BioSciences, Inc. and Chief Executive Officer & Director at Novelos Therapeutics, Inc. (a subsidiary of Cellectar BioSciences, Inc.), President, Chief Executive Officer & Director at Chelsea Therapeutics International Ltd., President & Chief Executive Officer of Chelsea Therapeutics, Inc., President & Chief Executive Officer of Ivory Capital Corp., Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc., Vice President-Drug Development at Shearwater Corp. and Member of the University of Saskatchewan College of Medicine.

He received an undergraduate degree from The University of Waterloo, a graduate degree from Concordia University and a doctorate from the University of Saskatchewan College of Medicine.


Date Shares Transaction Value
04/09/2020 20,901   Derivative/Non-derivative trans. at $2.57 per share. 53,716
08/27/2019 6,734   Acquisition at $2.98 per share. 20,067
05/24/2019 250,000   Award at $0 per share. 0
05/14/2019 6,000   Acquisition at $5.06 per share. 30,360

Officers and Executives

Mr. Michael F. Cola
Chief Executive Officer & Director
Dr. Simon C. Pedder
President & Director
Mr. Christopher Sullivan
Chief Financial & Accounting Officer
Dr. Garry Arthur Neil
Chief Medical Officer
Dr. H. Jeffrey Wilkins
Chief Development Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Dr. Uli Alf Hacksell
Mr. Joseph M. Miller
Mr. James A. Harrell
Chief Commercial Officer
Dr. Sol J. Barer
Dr. Suzanne Louise Bruhn
Independent Director
Mr. Keith W. Schmidt
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phil Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
Powered by StockTwits
Link to MarketWatch's Slice.